Catalyst Wire Dossier Catalyst Wire Dossier

IL-23 inhibitors

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL-23 inhibitors, covering 2025-09-19 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Real-World Study on the Safety and Effectiveness of IL-23 Inhibitors for Inflammatory Bowel Disease in China

See pricing